Table 1.
Characteristics | Value |
---|---|
Age, years | 62.4 (21–78) |
BMI, kg/m2 | 25.7 (16.4–36.4) |
Sex, Women/Men | 22/13 |
The cause of lymphedema | |
Complication of malignant tumor treatment | 24 (68.6%) |
Primary | 6 (17.1%) |
Cellulitis | 5 (14.3%) |
Duration of edema, m | 52.5 (1–360) |
≥1 past cellulitis episode(s) | 11 (31.4%) |
LEL index | 272.4 (180.7–384.8) |
Lymphoscintigraphy staging | |
I | 7 (20%) |
II | 5 (14.3%) |
III | 3 (8.6%) |
IV | 12 (34.3%) |
V | 8 (22.9%) |
ICG lymphography staging | |
I | 8 (22.9%) |
II | 3 (8.6%) |
III | 14 (40%) |
IV | 4 (11.4%) |
V | 6 (17.1%) |
NECST classification | |
0 | 3 (8.6%) |
I | 8 (22.9%) |
II | 8 (22.9%) |
III | 13 (37.1%) |
IV | 3 (8.6%) |
The type of surgery | |
LVA | 25 (71.4%) |
LVA and VLT | 5 (14.3%) |
LVA and LS | 2 (5.7%) |
LVA, VLT and LS | 3 (8.6%) |
BMI, body mass index; LEL, lower extremity lymphedema; ICG, indocyanine green; NECST, normal, ectasis, contraction, and sclerosis type classification; LVA, lymphatic venous anastomosis; VLT, vascularized lymphatic channel transfer; LS, liposuction.